Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2017 May 23;55(6):1970. doi: 10.1128/JCM.00525-17

Correction for Evans et al., “Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III”

Scott R Evans a, Andrea M Hujer b,c, Hongyu Jiang a, Carol B Hill d, Kristine M Hujer b,c, Jose R Mediavilla e, Claudia Manca e, Thuy Tien T Tran a, T Nicholas Domitrovic b,c, Paul G Higgins f,g, Harald Seifert f,g, Barry N Kreiswirth e, Robin Patel h, Michael R Jacobs i, Liang Chen e, Rangarajan Sampath j, Thomas Hall j, Christine Marzan j, Vance G Fowler Jr d,k, Henry F Chambers l, Robert A Bonomo b,c,m, for the Antibacterial Resistance Leadership Group (ARLG)
PMCID: PMC5442558  PMID: 28536161

AUTHOR CORRECTION

Volume 55, no. 1, p. 134–144, 2017, https://doi.org/10.1128/JCM.01524-16. Table S1 in the supplemental material: Isolates PR-369 and PR-469 were mislabeled, and a column containing an alternate list of isolate names (ARLG IDs) was inadvertently omitted. Revised supplemental material is posted at http://jcm.asm.org/content/55/1/134/suppl/DCSupplemental.


Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES